Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Department of Orthopedic Surgery and Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA.
J Bone Miner Res. 2021 May;36(5):986-999. doi: 10.1002/jbmr.4248. Epub 2021 Feb 8.
Endochondral ossification is tightly controlled by a coordinated network of signaling cascades including parathyroid hormone (PTH). Pleckstrin homology (PH) domain and leucine rich repeat phosphatase 1 (Phlpp1) affects endochondral ossification by suppressing chondrocyte proliferation in the growth plate, longitudinal bone growth, and bone mineralization. As such, Phlpp1 mice have shorter long bones, thicker growth plates, and proportionally larger growth plate proliferative zones. The goal of this study was to determine how Phlpp1 deficiency affects PTH signaling during bone growth. Transcriptomic analysis revealed greater PTH receptor 1 (Pth1r) expression and enrichment of histone 3 lysine 27 acetylation (H3K27ac) at the Pth1r promoter in Phlpp1-deficient chondrocytes. PTH (1-34) enhanced and PTH (7-34) attenuated cell proliferation, cAMP signaling, cAMP response element-binding protein (CREB) phosphorylation, and cell metabolic activity in Phlpp1-inhibited chondrocytes. To understand the role of Pth1r action in the endochondral phenotypes of Phlpp1-deficient mice, Phlpp1 mice were injected with Pth1r ligand PTH (7-34) daily for the first 4 weeks of life. PTH (7-34) reversed the abnormal growth plate and long-bone growth phenotypes of Phlpp1 mice but did not rescue deficits in bone mineral density or trabecular number. These results show that elevated Pth1r expression and signaling contributes to increased proliferation in Phlpp1 chondrocytes and shorter bones in Phlpp1-deficient mice. Our data reveal a novel molecular relationship between Phlpp1 and Pth1r in chondrocytes during growth plate development and longitudinal bone growth. © 2021 American Society for Bone and Mineral Research (ASBMR).
软骨内骨化受甲状旁腺激素 (PTH) 等信号级联的协调网络严格控制。pleckstrin 同源 (PH) 结构域和富含亮氨酸重复的磷酸酶 1 (Phlpp1) 通过抑制生长板中的软骨细胞增殖、纵向骨生长和骨矿化来影响软骨内骨化。因此,Phlpp1 小鼠的长骨更短,生长板更厚,生长板增殖区比例更大。本研究的目的是确定 Phlpp1 缺乏如何影响骨生长过程中的 PTH 信号。转录组分析显示 Phlpp1 缺陷型软骨细胞中 PTH 受体 1 (Pth1r) 的表达增加,并且 Pth1r 启动子处的组蛋白 3 赖氨酸 27 乙酰化 (H3K27ac) 富集。PTH (1-34) 增强和 PTH (7-34) 减弱了 Phlpp1 抑制的软骨细胞中的细胞增殖、cAMP 信号、cAMP 反应元件结合蛋白 (CREB) 磷酸化和细胞代谢活性。为了了解 Pth1r 作用在 Phlpp1 缺陷型小鼠软骨内表型中的作用,在生命的前 4 周内每天给 Phlpp1 小鼠注射 Pth1r 配体 PTH (7-34)。PTH (7-34) 逆转了 Phlpp1 小鼠的异常生长板和长骨生长表型,但不能挽救骨密度或小梁数的缺陷。这些结果表明,Pth1r 表达和信号的升高导致 Phlpp1 软骨细胞增殖增加和 Phlpp1 缺陷型小鼠骨骼变短。我们的数据揭示了生长板发育和纵向骨生长过程中 Phlpp1 和 Pth1r 之间的新型分子关系。